期刊
FRONTIERS IN CARDIOVASCULAR MEDICINE
卷 9, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fcvm.2022.861651
关键词
acute heart failure (AHF); galectin-3 (Gal-3); cardiorenal syndrome (CRS); renal function; prognosis
资金
- Redes Tematicas de Investigacion Cooperativa en Salud del Instituto de Salud Carlos III (REDINSCOR), Madrid, Spain [RD06-0003-0000]
- Red de Investigacion Cardiovascular del Instituto de Salud Carlos III (RIC), Madrid, Spain [RD12/0042/0002]
This study investigated the relationship between the inflammatory marker Galectin-3 and renal function in patients with acute heart failure. The results showed that renal function influences the prognostic value of Galectin-3 levels in these patients.
IntroductionGalectin-3 (Gal-3) is an inflammatory marker associated with the development and progression of heart failure (HF). A close relationship between Gal-3 levels and renal function has been observed, but data on their interaction in patients with acute HF (AHF) are scarce. We aim to assess the prognostic relationship between renal function and Gal-3 during an AHF episode. Materials and MethodsThis is an observational, prospective, multicenter registry of patients hospitalized for AHF. Patients were divided into two groups according to estimated glomerular filtration rate (eGFR): preserved renal function (eGFR >= 60 mL/min/1.73 m(2)) and renal dysfunction (eGFR <60 mL/min/1.73 m(2)). Cox regression analysis was performed to evaluate the association between Gal-3 and 12-month mortality. ResultsWe included 1,201 patients in whom Gal-3 values were assessed at admission. The median value of Gal-3 in our population was 23.2 ng/mL (17.3-32.1). Gal-3 showed a negative correlation with eGFR (rho = -0.51; p < 0.001). Gal-3 concentrations were associated with higher mortality risk in the multivariate analysis after adjusting for eGFR and other prognostic variables [HR = 1.010 (95%-CI: 1.001-1.018); p = 0.038]. However, the prognostic value of Gal-3 was restricted to patients with renal dysfunction [HR = 1.010 (95%-CI: 1.001-1.019), p = 0.033] with optimal cutoff point of 31.5 ng/mL, with no prognostic value in the group with preserved renal function [HR = 0.990 (95%-CI: 0.964-1.017); p = 0.472]. ConclusionsGal-3 is a marker of high mortality in patients with acute HF and renal dysfunction. Renal function influences the prognostic value of Gal-3 levels, which should be adjusted by eGFR for a correct interpretation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据